Jiangsu Hengrui Pharmaceuticals Co Ltd. JIANGSU HENGRUI MEDICINE

Jiangsu Hengrui Pharmaceuticals Co Ltd. JIANGSU HENGRUI MEDICINE is a security (CUSIP Y4446S105) tracked across SEC portfolio filings. 1 registered fund positions totaling $274K via N-PORT as of 2026-03-31.

Summary

Top fund holders (N-PORT)

FundRegistrantValue% of fund
Rayliant-ChinaAMC Transformative China Tech ETFRayliant Funds Trust$274K165.84%

More